Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection Fraction
Heart failure (HF), with steadily increasing incidence rates and mortality in an ageing population, represents a major challenge. Evidence suggests that more than half of all patients with a diagnosis of HF suffer from HF with preserved ejection fraction (HFpEF). Emerging novel biomarkers to improve...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Radcliffe Medical Media
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/57e92d1e8d0b496e8595bd47bf1ccf5b |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|